C10B |
C10B Lipid modifying agents, combinations |
C10BA |
C10BA HMG CoA reductase inhibitors in combination with other lipid modifying agents |
C10BA01 |
C10BA01 lovastatin and nicotinic acid |
C10BA02 |
C10BA02 simvastatin and ezetimibe |
C10BA03 |
C10BA03 pravastatin and fenofibrate |
C10BA04 |
C10BA04 Simvastatin and Fenofibrate |
C10BA05 |
C10BA05 atorvastatin and ezetimibe |
C10BA06 |
C10BA06 rosuvastatin and ezetimibe |
C10BA07 |
C10BA07 Rosuvastatin And Omega-3 Fatty Acids |
C10BA08 |
C10BA08 Atorvastatin And Omega-3 Fatty Acids |
C10BA09 |
C10BA09 Rosuvastatin And Fenofibrate |
C10BX |
C10BX HMG CoA reductase inhibitors, other combinations |
C10BX01 |
C10BX01 simvastatin and acetylsalicylic acid |
C10BX02 |
C10BX02 pravastatin and acetylsalicylic acid |
C10BX03 |
C10BX03 atorvastatin and amlodipine |
C10BX04 |
C10BX04 simvastatin, acetylsalicylic acid and ramipril |
C10BX05 |
C10BX05 rosuvastatin and acetylsalicylic acid |
C10BX06 |
C10BX06 atorvastatin, acetylsalicylic acid and ramipril |
C10BX07 |
C10BX07 rosuvastatin, amlodipine and lisinopril |
C10BX08 |
C10BX08 atorvastatin and acetylsalicylic acid |
C10BX09 |
C10BX09 rosuvastatin and amlodipine |
C10BX10 |
C10BX10 rosuvastatin and valsartan |
C10BX11 |
C10BX11 atorvastatin, amlodipine and perindopril |
C10BX12 |
C10BX12 atorvastatin, acetylsalicylic acid and perindopril |
C10BX13 |
C10BX13 Rosuvastatin, Perindopril And Indapamide |
C10BX14 |
C10BX14 Rosuvastatin, Amlodipine And Perindopril |
C10BX15 |
C10BX15 Atorvastatin And Perindopril |
C10BX16 |
C10BX16 Rosuvastatin And Fimasartan |
C10BX17 |
C10BX17 Rosuvastatin And Ramipril |
D |
D Dermatologicals |